-
公开(公告)号：US20220169982A1
公开(公告)日：2022-06-02
申请号：US17552743
申请日：2021-12-16
Applicant: CELL CURE NEUROSCIENCES LTD.
Inventor： Osnat Bohana-Kashtan , Lior Ann Rosenberg Belmaker , Ofer Wiser
Abstract: A population of human polygonal RPE cells is disclosed. At least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms. Methods of generating same are also disclosed.
-
公开(公告)号：US20210332325A1
公开(公告)日：2021-10-28
申请号：US17323441
申请日：2021-05-18
Applicant: Cell Cure Neurosciences Ltd.
Inventor： Osnat Bohana-Kashtan , Lior Ann Rosenberg Belmaker , Ofer Wiser
Abstract: A population of human polygonal RPE cells is disclosed. At least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms. Methods of generating same are also disclosed.
-
公开(公告)号：US20180008458A1
公开(公告)日：2018-01-11
申请号：US15539565
申请日：2015-04-30
Applicant: Cell Cure Neurosciences Ltd.
Inventor： Eyal Banin , Benjamin Eithan Reubinoff , Osnat Bohana-Kashtan , Nir Netzer , Charles Sherard Irving
CPC classification number: A61F9/0008 , A61F9/00727 , A61K35/30 , A61K38/1709 , A61K2035/124 , C12N5/0621
Abstract: A method of treating a subject with dry-form age-related macular degeneration (AMD) is disclosed. The method comprises administering into the subretina of the subject a therapeutically effective amount of a pharmaceutical composition comprising human RPE cells, wherein at least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms to the subject, thereby treating the subject.
-
公开(公告)号：US12203097B2
公开(公告)日：2025-01-21
申请号：US17355093
申请日：2021-06-22
Applicant: Cell Cure Neurosciences LTD
Inventor： Osnat Bohana-Kashtan , Ofer Wiser
IPC: C12N5/079
Abstract: A method of generating retinal pigment epithelium cells is disclosed. Cell populations comprising same and uses thereof are also disclosed.
-
公开(公告)号：US20220169981A1
公开(公告)日：2022-06-02
申请号：US17546011
申请日：2021-12-08
Applicant: Cell Cure Neurosciences Ltd.
Inventor： Osnat Bohana-Kashtan , Lior Ann Rosenberg Belmaker , Ofer Wiser
Abstract: A population of human polygonal RPE cells is disclosed. At least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms. Methods of generating same are also disclosed.
-
Patent Agency Ranking
公开(公告)号：US11066642B2
公开(公告)日：2021-07-20
申请号：US15750108
申请日：2016-08-04
Applicant: CELL CURE NEUROSCIENCES LTD
Inventor： Osnat Bohana-Kashtan , Ofer Wiser
IPC: C12N5/079
Abstract: A method of generating retinal pigment epithelium cells is disclosed. Cell populations comprising same and uses thereof are also disclosed.
-
公开(公告)号：US20180230426A1
公开(公告)日：2018-08-16
申请号：US15750108
申请日：2016-08-04
Applicant: CELL CURE NEUROSCIENCES LTD.
Inventor： Osnat Bohana-Kashtan , Ofer Wiser
IPC: C12N5/079
CPC classification number: C12N5/0621 , C12N2500/38 , C12N2500/98 , C12N2501/115 , C12N2501/15 , C12N2506/02 , C12N2533/52 , C12N2533/54
Abstract: A method of generating retinal pigment epithelium cells is disclosed. Cell populations comprising same and uses thereof are also disclosed.
-
公开(公告)号：US20240301351A1
公开(公告)日：2024-09-12
申请号：US18662758
申请日：2024-05-13
Applicant: CELL CURE NEUROSCIENCES LTD.
Inventor： Osnat Bohana-Kashtan , Lior Ann Rosenberg Belmaker , Ofer Wiser
CPC classification number: C12N5/0621 , A61K35/30 , C12N2500/02 , C12N2500/38 , C12N2501/115 , C12N2501/15 , C12N2501/16 , C12N2506/02 , C12N2533/52
Abstract: A population of human polygonal RPE cells is disclosed. At least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms. Methods of generating same are also disclosed.
-
公开(公告)号：US11987810B2
公开(公告)日：2024-05-21
申请号：US17546013
申请日：2021-12-08
Applicant: Cell Cure Neurosciences Ltd.
Inventor： Osnat Bohana-Kashtan , Lior Ann Rosenberg Belmaker , Ofer Wiser
CPC classification number: C12N5/0621 , A61K35/30 , C12N2500/02 , C12N2500/38 , C12N2501/115 , C12N2501/15 , C12N2501/16 , C12N2506/02 , C12N2533/52
Abstract: A population of human polygonal RPE cells is disclosed. At least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms. Methods of generating same are also disclosed.
-
公开(公告)号：US20230028133A1
公开(公告)日：2023-01-26
申请号：US17943462
申请日：2022-09-13
Applicant: CELL CURE NEUROSCIENCES LTD.
Inventor： Eyal Banin , Benjamin Eithan Reubinoff , Osnat Bohana-Kashtan , Nir Netzer , Charles Sherard Irving
Abstract: A method of treating a subject with dry-form age-related macular degeneration (AMD) is disclosed. The method comprises administering into the subretina of the subject a therapeutically effective amount of a pharmaceutical composition comprising human RPE cells, wherein at least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), and wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms to the subject, thereby treating the subject.
-
-
-
-
-
-
-
-
-
Search Results
18
records
(took 0.016 seconds)
